Therapeutic delivery of carbon monoxide: WO2008/003953

Expert Opinion on Therapeutic Patents

Volumn 18, Issue 11, 2008, Pages 1321-1325

  Zuckerbraun, Brian S ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Carbon monoxide; Carbon monoxide releasing molecules; CORMs; Inflammation; Transition metal carbonyl compounds

Indexed keywords

CARBON MONOXIDE; CARBON MONOXIDE RELEASING MOLECULE; HEMOGLOBIN; LIPOPOLYSACCHARIDE; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASPHYXIA; CATALYSIS; CELL VIABILITY; CYTOTOXICITY; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG PROTEIN BINDING; DRUG RELEASE; DRUG SOLUBILITY; DRUG STRUCTURE; DRUG SYNTHESIS; NONHUMAN; PATENT; PHYSICAL CHEMISTRY; PROTEIN DEGRADATION; PROTEIN EXPRESSION; VASODILATATION;

EID: 56849083269     PISSN: 13543776     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543776.18.11.1321     Document Type: Article

References (22)

1. Motterlini R, Mann BE, Scapens D; inventors. Therapeutic delivery of carbon monoxide patent WO08/003953; 2008
2. Piantadosi CA. Biological chemistry of carbon monoxide. Antioxid Redox Signal 2002;4(2):259-70
3. Bernard C. Lecons sur les effets des substances toxiques et medicamenteuses. Paris: Bailliere; 1857
4. Haldane J. The relation of the action of carbonic oxide to oxygen tension. J Physiol 1895;18(3):201-17
5. Chance B, Williams GR. The respiratory chain and oxidative phosphorylation. Adv Enzymol Relat Subj Biochem 1956;17:65-134
6. Coburn RF, Williams WJ, Kahn SB. Endogenous carbon monoxide production in patients with hemolytic anemia. J Clin Invest 1966;45(4):460-8
7. Cobum RF, Williams WJ, White P, Kahn SB. The production of carbon monoxide from hemoglobin in vivo. J Clin Invest 1967;46(3):346-56
8. Tenhunen R, Marver HS, Schmid R. The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc Natl Acad Sci USA 1968;61(2):748-55
9. Verma A, Hirsch DJ, Glatt CE, et al. Carbon monoxide: a putative neural messenger. Science 1993;259(5093):381-4
10. Otterbein LE, Choi AM. Heme oxygenase: colors of defense against cellular stress. Am J Physiol Lung Cell Mol Physiol 2000;279(6):L1029-37
11. Otterbein LE, Soares MP, Yamashita K, Bach FH. Heme oxygenase-1: unleashing the protective properties of heme. Trends Immunol 2003;24(8):449-55
12. Kaczorowski DJ, Zuckerbraun BS. Carbon monoxide: medicinal chemistry and biological effects. Curr Med Chem 2007;14(25):2720-5
13. Otterbein LE. Carbon monoxide: innovative anti-inflammatory properties of an age-old gas molecule. Antioxid Redox Signal 2002;4(2):309-19
14. Bach FH, Tobiasch E, Soares M, et al. inventors. Carbon monoxide improves outcomes in tissue and organ transplants and suppreses apoptosis. WO2003000114;2003
15. Choi AM, Otterbein L; inventors. Carbon monoxide as a biomarker and therapeutic agent. WO2003094932;2003
16. Haas W, Romao C, Royo B, Fernandes AC, Goncalves I; inventors. Method for treating a mammal by administration of a compound having the ability to release CO. WO2003066067;2003
17. Motterlini R, Mann BE; inventors. Therapeutic delivery of carbon monoxide to extracorporeal and isolated organs. WO2004045598;2004
18. Motterlini R, Mann BE; inventors. Therapeutic delivery of carbon monoxide. WO2002092075;2002
19. Otterbein L, Choi AM, Bach FH, Zuckerbraun BS; inventors. Methods of treating vascular disease. WO2003072024;2003
20. Motterlini R, Mann BE, Foresti R. Therapeutic applications of carbon monoxide-releasing molecules. Expert Opin Investig Drugs 2005;14(11):1305-18
21. Otterbein LE, Bach FH, Alam J, et al. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med 2000;6(4):422-8
22. Sawle P, Foresti R, Mann BE, et al. Carbon monoxide-releasing molecules (CO-RMs) attenuate the inflammatory response elicited by lipopolysaccharide in RAW264.7 murine macrophages. Br J Pharmacol 2005;145(6):800-10